MedPath

SANDOZ VORICONAZOLE

SANDOZ VORICONAZOLE

Approved
DIN Number

02399245

Drug Class

Human

Market Date

Apr 2, 2014

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02399245
AIG Number0150242001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J02AC03 VORICONAZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:14.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

VORICONAZOLEActive
Strength: 50 MG
Monograph: VORICONAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.